CTOs on the Move

GlaxoSmithKline

www.gsk.com

 
We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization`s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.gsk.com
  • 5 Crescent Drive
    Philadelphia, PA USA 19112
  • Phone: 215.751.7160

Executives

Name Title Contact Details
Delfim Martins
VP Cyber Defense Profile
Lisa Ackerman
Deputy CISO, Cyber Security Strategy and Solutions Profile
Jeff Wrona
Senior Director, Security Infrastructure, Global Security Operations, GSK Profile
Tara Jaques
Sr. Director, Security Posture and Assurance Profile
Jon Frampton
Director, Data Security Services Profile

Similar Companies

Groups

Groups Recover Together offers medication-assisted treatment (MAT) for opioid addiction. We can prescribe Buprenorphine (Suboxone) medication you need today to stop feeling sick, and a supportive community you can rely on to help you to succeed.

The Oregon Clinic

The Oregon Clinic is the largest private specialty physician practice in Oregon, with more than 200 providers practicing over 30 different medical and surgical specialties and sub-specialties. An evidence-based, multidisciplinary organization, The Oreg...

Ajinomoto AminoScience

Ajinomoto AminoScience is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrthoLive

OrthoLives mission is to leverage telehealth to streamline orthopedic care so practices and businesses can treat patients quickly.

Virpax Pharmaceuticals

Virpax`s lead product candidate, Probudur, is being developed using our proprietary liposomal encapsulation to deliver a sustain release of local anesthetic at the wound/incision site to control post-operative pain for 96 hours. We have executed Cooperative Research and Development Agreements (CRADA), as well as the National Institute of Health/NCATS; U.S. Army Institute of Surgical Research/Department of Defense to develop differentiated non-addictive treatment options and the Epilepsy Therapy Screening Program (ETSP) which is focused on focused on addressing drug resistant epilepsy, disease prevention and modification. The three products in development are targeting unmet global needs in three separate multi-billion-dollar markets, including rare diseases. Our proprietary drug-delivery-platforms have been developed to optimize the efficacy of nonaddictive medications to manage Post Operative Pain, Severe Pain, Post Cancer Pain, PTSD, and Rare Pediatric Epilepsy including Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (Orphan Diseases)